These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 18261573)

  • 1. Impact of calcineurin inhibitors on bone metabolism in primary kidney transplant patients.
    Bozkaya G; Nart A; Uslu A; Onman T; Aykas A; Doğan M; Karaca B
    Transplant Proc; 2008; 40(1):151-5. PubMed ID: 18261573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of tacrolimus vs cyclosporin-A on bone metabolism after kidney transplantation: a cross-sectional study in 28 patients].
    Albano L; Casez JP; Bekri S; Gigante M; Champenois I; Cassuto-Viguier E; Jaeger P
    Nephrol Ther; 2005 May; 1(2):115-20. PubMed ID: 16895674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive agents and bone disease in renal transplant patients with hypercalcemia.
    Sessa A; Esposito A; Iavicoli GD; Lettieri E; Dente G; Costa C; Bergallo M; Rossano R; Capuano M
    Transplant Proc; 2010 May; 42(4):1148-55. PubMed ID: 20534247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
    Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression.
    Hernández D; Miquel R; Porrini E; Fernández A; González-Posada JM; Hortal L; Checa MD; Rodríguez A; García JJ; Rufino M; Torres A
    Transplantation; 2007 Sep; 84(6):706-14. PubMed ID: 17893603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Slowing progression of chronic allograft nephropathy by conversion from cyclosporin A to tacrolimus].
    Peng LK; Xie XB; Peng FH; Wang Y; Jiang Y; Lan GB; Fang CH; Nie MH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):59-62. PubMed ID: 17344588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistently increased bone turnover and low bone density in long-term survivors to kidney transplantation.
    Giannini S; D'Angelo A; Carraro G; Antonello A; Di Landro D; Marchini F; Plebani M; Zaninotto M; Rigotti P; Sartori L; Crepaldi G
    Clin Nephrol; 2001 Nov; 56(5):353-63. PubMed ID: 11758005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of testosterone in cyclosporine-induced osteopenia.
    Bowman AR; Sass DA; Dissanayake IR; Ma YF; Liang H; Yuan Z; Jee WS; Epstein S
    J Bone Miner Res; 1997 Apr; 12(4):607-15. PubMed ID: 9101372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term bone loss after renal transplantation: comparison of immunosuppressive regimens.
    McIntyre HD; Menzies B; Rigby R; Perry-Keene DA; Hawley CM; Hardie IR
    Clin Transplant; 1995 Feb; 9(1):20-4. PubMed ID: 7742578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical inflammation in renal transplant recipients: impact of cyclosporine microemulsion versus tacrolimus.
    Lauzurica R; Pastor MC; Bayes B; Malumbres S; Homs M; Llopis MA; Bonet J; Romero R
    Transplant Proc; 2007 Sep; 39(7):2170-2. PubMed ID: 17889127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation.
    Goffin E; Devogelaer JP; Lalaoui A; Depresseux G; De Naeyer P; Squifflet JP; Pirson Y; van Ypersele de Strihou C
    Transpl Int; 2002 Mar; 15(2-3):73-80. PubMed ID: 11935163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation.
    Porrini E; Delgado P; Alvarez A; Cobo M; Pérez L; González-Posada JM; Hortal L; Gallego R; García JJ; Checa M; Morales A; Salido E; Hernández D; Torres A
    Nephrol Dial Transplant; 2008 Apr; 23(4):1436-41. PubMed ID: 18029372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
    Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
    Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone metabolism in renal transplant patients treated with cyclosporine or sirolimus.
    Campistol JM; Holt DW; Epstein S; Gioud-Paquet M; Rutault K; Burke JT;
    Transpl Int; 2005 Sep; 18(9):1028-35. PubMed ID: 16101723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum insulin/like growth factor I, bone mineral density and biochemical markers of bone metabolism in children with idiopathic osteoporosis.
    Chlebna-Sokol D; Rusinska A
    Endocr Regul; 2001 Dec; 35(4):201-8. PubMed ID: 11858767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcineurin inhibitors and Clostridium difficile infection in adult lung transplant recipients: the effect of cyclosporine versus tacrolimus.
    Lee JT; Whitson BA; Kelly RF; D'Cunha J; Dunitz JM; Hertz MI; Shumway SJ
    J Surg Res; 2013 Sep; 184(1):599-604. PubMed ID: 23566442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function.
    Watson CJ; Gimson AE; Alexander GJ; Allison ME; Gibbs P; Smith JC; Palmer CR; Bradley JA
    Liver Transpl; 2007 Dec; 13(12):1694-702. PubMed ID: 18044728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.